Text and Data Mining valid from 2020-01-13
Received: 25 August 2019
Accepted: 2 January 2020
First Online: 13 January 2020
Ethics approval and consent to participate
: Ethical approval was obtained from the institutional review board at the University of Gothenburg.
: Approval was obtained from patient or relatives.
: None of the authors has a financial relationship with a commercial entity that has an interest in the subject of the presented manuscript or other conflicts of interest to disclose. However, GD has a research grants from Astellas A/S for a study in immunosuppression after lung transplantation (the ScanCLAD study, ExternalRef removed Identifier: NCT02936505) and from Abbott regarding a destination therapy study on LVAD (the SweVAD study, ExternalRef removed Identifier: NCT02592499), both of them investigator-initiated and none of which we think is relevant for the content of this study.